Opus Genetics: Asymmetric Upside With LCA5 And BEST1
Source: SeekingAlpha
2026-02-22 21:35:18 ET
...
Read the full article on Seeking Alpha
For further details see:
Opus Genetics: Asymmetric Upside With LCA5 And BEST1
Opus Genetics Inc.
NASDAQ: IRD
IRD Trading
6.49% G/L:
$4.92 Last:
606,688 Volume:
$4.77 Open:
IRD Latest News
February 27, 2026 10:10:00 am
Opus Genetics Announces Initial Clinical Data from Phase 1/2 OPGx-BEST1 Gene Therapy Study at the Macula Society Annual Meeting
IRD Stock Data
$240,685,086
64,412,570
5.97%
14
N/A
Biotechnology & Life Sciences
Healthcare
US
Durham
